⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for autologous hematopoietic stem cell transplant (hsct)

Every month we try and update this database with for autologous hematopoietic stem cell transplant (hsct) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma PatientsNCT01009840
Multiple Myelom...
IV busulfan
bortezomib
Autologous Hema...
18 Years - 75 YearsOtsuka Pharmaceutical Development & Commercialization, Inc.
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCLNCT00490529
Lymphoma, Mantl...
CpG-MCL vaccine
PF-3512676
Vaccine-primed ...
Autologous hema...
Rituximab
Standard induct...
Cyclophosphamid...
Filgrastim
21 Years - 70 YearsStanford University
IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma PatientsNCT01009840
Multiple Myelom...
IV busulfan
bortezomib
Autologous Hema...
18 Years - 75 YearsOtsuka Pharmaceutical Development & Commercialization, Inc.
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCLNCT00490529
Lymphoma, Mantl...
CpG-MCL vaccine
PF-3512676
Vaccine-primed ...
Autologous hema...
Rituximab
Standard induct...
Cyclophosphamid...
Filgrastim
21 Years - 70 YearsStanford University
IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma PatientsNCT01009840
Multiple Myelom...
IV busulfan
bortezomib
Autologous Hema...
18 Years - 75 YearsOtsuka Pharmaceutical Development & Commercialization, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: